Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease

Published:2013-12-12 Issue:4 Volume:81 Page:523-528
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Kahal H.¹²,Abouda G.³,Rigby A. S.²,Coady A. M.⁴,Kilpatrick E. S.⁵,Atkin S. L.¹

Affiliation:

1. Academic Endocrinology, Diabetes and Metabolism; Hull York Medical School; Hull UK

2. Centre for Cardiovascular and Metabolic Research; Hull York Medical School; Hull UK

3. Department of Gastroenterology; Hull and East Yorkshire Hospitals NHS Trust; Hull UK

4. Department of Radiology; Hull and East Yorkshire Hospitals NHS Trust; Hull UK

5. Clinical Biochemistry; Hull and East Yorkshire Hospitals NHS Trust; Hull UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference35 articles.

1. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group;Fauser;Fertility and Sterility,2012

2. Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy;Glueck;European Journal of Obstetrics, Gynecology, and Reproductive Biology,2005

3. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome;Setji;Journal of Clinical Endocrinology and Metabolism,2006

4. Obesity-associated liver disease;Marchesini;Journal of Clinical Endocrinology and Metabolism,2008

5. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study;Poonawala;Hepatology,2000

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives;Life Sciences;2024-09

2. Association between polycystic ovary syndrome and risk of non-alcoholic fatty liver disease: a meta-analysis;Endokrynologia Polska;2023-10-30

3. Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies;Journal of Clinical Medicine;2023-09-12

4. Histological and immunohistochemical study of the effect of liraglutide in experimental model of non-alcoholic fatty liver disease;Egyptian Journal of Basic and Applied Sciences;2023-04-21

5. Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression;Journal of Clinical Medicine;2023-01-20